Global Topical Drug Delivery Market will be worth USD 205.1 billion by 2024 – New market report by Data Bridge Market Research

December 12 20:07 2016

“Global Topical Drug Delivery Market is expected to grow at 9.2% in the forecast period 2017 to 2024”
Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

Global Topical Drug Delivery Market is expected to reach USD 205.1 billion by 2024, from USD 101.7 billion in 2016 growing at a CAGR of 9.2% during the forecast period of 2017 to 2024.

Global Topical Drug Delivery Market is segmented based on product type, distribution channel, end user and geography.

For Sample Report: Global Topical Drug Delivery Market – Trends and Forecast to 2024

On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositors. The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.

To read more about the scope and findings of this report visit: Global Topical Drug Delivery Market is poised to grow at 9.2% till 2024

On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.

Based on distribution channel the market is segmented into Direct Tenders and Retail.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market covers data points for countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

KEY PLAYERS OPERATING IN GLOBAL TOPICAL DRUG DELIVERY MARKET:

  • MedPharm
  • Janssen Pharmaceuticals, Inc. (A J&J Company)
  • Crescita Therapeutics
  • West Pharmaceutical Services
  • Galderma S.A.
  • Biofarmitalia s.r.l
  • Pharmatek Laboratories, Inc.
  • Stiefel Laboratories, Inc.
  • Tapemark
  • Acrux Limited
  • Nitto Denko Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Skinvisible Pharmaceuticals, Inc.
  • Mylan Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Pocono Coated Products LLC
  • TheraSolve NV.
  • Samyang Biopharmaceuticals Corporation
  • Lohmann Therapie-Systeme AG
  • Prosollus Pharmaceuticals
  • Easton Pharmaceuticals Inc.
  • Novosis AG
  • Antares Pharma, Inc.
  • Endo Pharmaceuticals Inc.
  • Transdermal Technologies, Inc.
  • Sheffield Pharmaceuticals, Inc.
  • Solvay
  • 3M Drug Delivery Systems.

To Browse Full Report and Pricing: Global Topical Drug Delivery Market – Trends and Forecast to 2024

Table of Content:

1. INTRODUCTION

    1.1. OVERVIEW OF THE GLOBAL TOPICAL DRUG DELIVERY MARKET

    1.2. MARKET SEGMENTATION & COVERAGE

          1.2.1. CURRENCY AND PRICING 

          1.2.2. LIMITATION

          1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

    2.1. KEY TAKEAWAYS

    2.2. ARRIVING AT THE GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE

          2.2.1. MARKET CRACKDOWN APPROACH 

          2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

          2.2.3. DATA TRIANGULATION

          2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

          2.2.5.  PRODUCT PIPELINE ANALYSIS

          2.2.6.  PORTER’S FIVE FORCES MATRIX

    2.3. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH SNAPSHOT

    2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

    4.1. OVERVIEW

    4.2. GLOBAL TOPICAL DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS

    4.3. MARKET OVERVIEW

          4.3.1. DRIVERS

                   4.3.1.1.   RISING PREVALENCE OF CHRONIC DISEASE SUCH AS DIABETES

                   4.3.1.2.   GROWTH IN TRANSDERMAL TECHNOLOGY

                   4.3.1.3.   INNOVATION AND DEVELOPMENT OF NEW DRUG TYPES

                   4.3.1.4.   BETTER HEALTHCARE SPENDING IN SOUTH ASIA AND AFRICA

           4.3.2. RESTRAINTS

           4.3.3. OPPURTUNITIES

           4.3.4. THREATS

     4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. EXECUTIVE SUMMARY

6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE

    6.1. OVERVIEW

    6.2. TOPICAL DRUG DELIVERY, BY PRODUCT TYPE

          6.2.1. TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE

                   6.2.1.1.  TRANSDERMAL PATCHES

                   6.2.1.2.  TRANSDERMAL GELS

          6.2.2. TOPICAL DRUG DELIVERY FORMULATIONS, BY FORM

                   6.2.2.1.  LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

                              6.2.2.1.1.  SOLUTIONS

                              6.2.2.1.2.  SUSPENSIONS

                   6.2.2.2.  SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

                               6.2.2.2.1.  GELS

                               6.2.2.2.2.  CREAMS

                               6.2.2.2.3.  OINTMENTS

                               6.2.2.2.4.  PASTES

                               6.2.2.2.5.  LOTIONS

                   6.2.2.3.  SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

                               6.2.2.3.1.  SUPPOSITORIES

                               6.2.2.3.2.  POWDERS

7. TOPICAL DRUG DELIVERY MARKET, BY END-USER

    7.1.      OVERVIEW

    7.2.      HOSPITALS

    7.3.      HOME HEALTHCARE

    7.4.      CLINICS

    7.5.      DIAGNOSTIC CENTERS

    7.6.      OTHERS

8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

    8.1.      OVERVIEW

    8.2.      HOSPITAL PHARMACIES

    8.3.      PHARMACY STORES

    8.4.      DIRECT TENDERS

    8.5.      ONLINE PHARMACY

9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY

    9.1.      COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN                  THIS CHAPTER BY COUNTRY)

               9.1.1.      NORTH AMERICA

                            9.1.1.1.      U.S.

                            9.1.1.2.      CANADA

                            9.1.1.3.      MEXICO

               9.1.2.      EUROPE

                            9.1.2.1.      GERMANY

                            9.1.2.2.      FRANCE

                            9.1.2.3.      U.K.

                            9.1.2.4.      ITALY

                            9.1.2.5.      SPAIN

                            9.1.2.6.      RUSSIA

                            9.1.2.7.      TURKEY

                            9.1.2.8.      BELGIUM

                            9.1.2.9.      NETHERLANDS

                            9.1.2.10.      SWITZERLAND

                            9.1.2.11.    REST OF EUROPE

            9.1.3.      ASIA-PACIFIC (APAC)

                          9.1.3.1.      JAPAN

                          9.1.3.2.      CHINA

                          9.1.3.3.      SOUTH KOREA

                          9.1.3.4.      INDIA

                          9.1.3.5.      AUSTRALIA

                          9.1.3.6.      SINGAPORE

                          9.1.3.7.      THAILAND

                          9.1.3.8.      MALAYSIA

                          9.1.3.9.      INDONESIA

                          9.1.3.10.      PHILIPPINES

                          9.1.3.11.      REST OF APAC

            9.1.4.    LATIN AMERICA

                          9.1.4.1.     BRAZIL

                          9.1.4.2.     REST OF LATIN AMERICA

            9.1.5.    MIDDLE EAST AND AFRICA

                          9.1.5.1.     SOUTH AFRICA

                          9.1.5.2.     REST OF MIDDLE EAST AND AFRICA

   9.2.      KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10        TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE

   10.1.   GLOBAL TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

   10.2.   U.S. TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

   10.3.   EUROPE TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

   10.4.   APAC TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

   10.5.   SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

   10.6.   MIDDLE EAST AND AFRICA  TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

   10.7.   MERGERS & ACQUISITIONS

   10.8.   NEW PRODUCT DEVELOPMENT & APPROVALS

   10.10. EXPANSIONS

   10.10. REGULATORY CHANGES

   10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11        TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES

   11.1    JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)

                         11.1.1   COMPANY OVERVIEW

                         11.1.2   SWOT ANALYSIS

                         11.1.3   REVENUE ANALYSIS

                         11.1.4   PRODUCT PORTFOLIO

                         11.1.5   RECENT DEVELOPEMENTS

                         11.1.5   DATA BRIDGE ANALYSIS

   11.2    CRESCITA THERAPEUTICS

                         11.2.1   COMPANY OVERVIEW

                         11.2.2   SWOT ANALYSIS

                         11.2.3   REVENUE ANALYSIS

                         11.2.4   PRODUCT PORTFOLIO

                         11.2.5   RECENT DEVELOPEMENTS

                         11.2.5   DATA BRIDGE ANALYSIS

   11.3    GALDERMA S.A.

                         11.3.1   COMPANY OVERVIEW

                         11.3.2   SWOT ANALYSIS

                         11.3.3   REVENUE ANALYSIS

                         11.3.4   PRODUCT PORTFOLIO

                         11.3.5   RECENT DEVELOPEMENTS

                         11.3.5   DATA BRIDGE ANALYSIS

   11.4    BIOFARMITALIA S.R.L

                         11.4.1   COMPANY OVERVIEW

                         11.4.2   SWOT ANALYSIS

                         11.4.3   REVENUE ANALYSIS

                         11.4.4   PRODUCT PORTFOLIO

                         11.4.5   RECENT DEVELOPEMENTS

                         11.4.5   DATA BRIDGE ANALYSIS

 

   11.5    PHARMATEK LABORATORIES, INC.

                         11.5.1   COMPANY OVERVIEW

                         11.5.2   SWOT ANALYSIS

                         11.5.3   REVENUE ANALYSIS

                         11.5.4   PRODUCT PORTFOLIO

                         11.5.5   RECENT DEVELOPEMENTS

                         11.5.5   DATA BRIDGE ANALYSIS

   11.6    STIEFEL LABORATORIES, INC.

                         11.6.1   COMPANY OVERVIEW

                         11.6.2   SWOT ANALYSIS

                         11.6.3   REVENUE ANALYSIS

                         11.6.4   PRODUCT PORTFOLIO

                         11.6.5   RECENT DEVELOPEMENTS

                         11.6.5   DATA BRIDGE ANALYSIS

   11.7    TAPEMARK

                         11.7.1   COMPANY OVERVIEW

                         11.7.2   SWOT ANALYSIS

                         11.7.3   REVENUE ANALYSIS

                         11.7.4   PRODUCT PORTFOLIO

                         11.7.5   RECENT DEVELOPEMENTS

                         11.7.5   DATA BRIDGE ANALYSIS

   11.8    NITTO DENKO CORPORATION

                         11.8.1   COMPANY OVERVIEW

                         11.8.2   SWOT ANALYSIS

                         11.8.3   REVENUE ANALYSIS

                         11.8.4   PRODUCT PORTFOLIO

                         11.8.5   RECENT DEVELOPEMENTS

                         11.8.5   DATA BRIDGE ANALYSIS

   11.9    VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   SWOT ANALYSIS

                         11.9.3   REVENUE ANALYSIS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   RECENT DEVELOPEMENTS

                         11.9.5   DATA BRIDGE ANALYSIS

   11.10    MYLAN PHARMACEUTICALS INC.

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   SWOT ANALYSIS

                         11.9.3   REVENUE ANALYSIS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   RECENT DEVELOPEMENTS

                         11.9.5   DATA BRIDGE ANALYSIS

   11.11    HISAMITSU PHARMACEUTICAL CO., INC.

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   SWOT ANALYSIS

                         11.9.3   REVENUE ANALYSIS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   RECENT DEVELOPEMENTS

                         11.9.5   DATA BRIDGE ANALYSIS

  11.12  THERASOLVE NV.

                         11.10.1   COMPANY OVERVIEW

                         11.10.2   SWOT ANALYSIS

                         11.10.3   REVENUE ANALYSIS

                         11.10.4   PRODUCT PORTFOLIO

                         11.10.5   RECENT DEVELOPEMENTS

                         11.10.5   DATA BRIDGE ANALYSIS

  11.13  SAMYANG BIOPHARMACEUTICALS CORPORATION

                         11.11.1   COMPANY OVERVIEW

                         11.11.2   SWOT ANALYSIS

                         11.11.3   REVENUE ANALYSIS

                         11.11.4   PRODUCT PORTFOLIO

                         11.11.5   RECENT DEVELOPEMENTS

                         11.11.5   DATA BRIDGE ANALYSIS

   11.14  LOHMANN THERAPIE-SYSTEME AG

                         11.12.1   COMPANY OVERVIEW

                         11.12.2   SWOT ANALYSIS

                         11.12.3   REVENUE ANALYSIS

                         11.12.4   PRODUCT PORTFOLIO

                         11.12.5   RECENT DEVELOPEMENTS

                         11.12.5   DATA BRIDGE ANALYSIS

   11.15  PROSOLLUS PHARMACEUTICALS

                         11.13.1   COMPANY OVERVIEW

                         11.13.2   SWOT ANALYSIS

                         11.13.3   REVENUE ANALYSIS

                         11.13.4   PRODUCT PORTFOLIO

                         11.13.5   RECENT DEVELOPEMENTS

                         11.13.5   DATA BRIDGE ANALYSIS

   11.16  EASTON PHARMACEUTICALS INC.

                         11.14.1   COMPANY OVERVIEW

                         11.14.2   SWOT ANALYSIS

                         11.14.3   REVENUE ANALYSIS

                         11.14.4   PRODUCT PORTFOLIO

                         11.14.5   RECENT DEVELOPEMENTS

                         11.14.5   DATA BRIDGE ANALYSIS

   11.15  ANTARES PHARMA, INC.

                         11.15.1   COMPANY OVERVIEW

                         11.15.2   SWOT ANALYSIS

                         11.15.3   REVENUE ANALYSIS

                         11.15.4   PRODUCT PORTFOLIO

                         11.15.5   RECENT DEVELOPEMENTS

                         11.15.5   DATA BRIDGE ANALYSIS

   11.16  ENDO PHARMACEUTICALS INC.

                         11.16.1   COMPANY OVERVIEW

                         11.16.2   SWOT ANALYSIS

                         11.16.3   REVENUE ANALYSIS

                         11.16.4   PRODUCT PORTFOLIO

                         11.16.5   RECENT DEVELOPEMENTS

                         11.16.5   DATA BRIDGE ANALYSIS 

   11.17  TRANSDERMAL TECHNOLOGIES, INC.

                         11.17.1   COMPANY OVERVIEW

                         11.17.2   SWOT ANALYSIS

                         11.17.3   REVENUE ANALYSIS

                         11.17.4   PRODUCT PORTFOLIO

                         11.17.5   RECENT DEVELOPEMENTS

                         11.17.5   DATA BRIDGE ANALYSIS

  11.18  SHEFFIELD PHARMACEUTICALS, INC.

                         11.18.1   COMPANY OVERVIEW

                         11.18.2   SWOT ANALYSIS

                         11.18.3   REVENUE ANALYSIS

                         11.18.4   PRODUCT PORTFOLIO

                         11.18.5   RECENT DEVELOPEMENTS

                         11.18.5   DATA BRIDGE ANALYSIS 

   11.19  SOLVAY

                         11.19.1   COMPANY OVERVIEW

                         11.19.2   SWOT ANALYSIS

                         11.19.3   REVENUE ANALYSIS

                         11.19.4   PRODUCT PORTFOLIO

                         11.19.5   RECENT DEVELOPEMENTS

                         11.19.5   DATA BRIDGE ANALYSIS

   11.20  3M DRUG DELIVERY SYSTEMS

                         11.20.1   COMPANY OVERVIEW

                         11.20.2   SWOT ANALYSIS

                         11.20.3   REVENUE ANALYSIS

                         11.20.4   PRODUCT PORTFOLIO

                         11.20.5   RECENT DEVELOPEMENTS

                         11.20.5   DATA BRIDGE ANALYSIS

12        APPENDIX

13        ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Infusion Pump Systems, Accessories and Software Market – Trends and Forecast to 2024

By Type (Infusion Pump Systems (Volumetric IP, Syringe IP, Ambulatory IP, Enteral IP, Insulin IP, Implantable IP, Chemotherapy IP, Anesthesia IP), Infusion Pump Accessories (Infusion Administration Sets, Valve Catheters, IV Sets, Needleless Connectors), Infusion Pump Management Software (Asset Management Modules, EMR Modules, Respiratory Monitoring Modules), By Application (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Enteral Infusion, Chemotherapy), By End-User (Hospitals, Ambulatory, Home Healthcare, Clinics), By Distribution Channel, By Geography (North America, Europe, APAC, South America, Middle East and Africa) – Trends and Forecast to 2024

Global Drug Delivery Devices Market – Trends and Forecast to 2022

By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/

  Categories: